Login

First International PTCOG Ocular Proton Therapy Symposium 2022

3–4 Mar 2022
Europe/Zurich timezone

Contact person

Contribution List

35 out of 35 displayed
Export to PDF
  1. 11. Clinical audit of different radiation modalities and different proton beams for ocular tumors
    Juliette Thariat
    03/03/2022, 14:14
  2. 12. Ocular late effects in long term survivors of uveal melanoma in adult and AYA patients treated by proton therapy
    Alessia Pica (PSI - Paul Scherrer Institut)
    03/03/2022, 14:23
  3. 13. Management of ocular side effects following proton beam radiotherapy for uveal melanoma
    Heinrich Heimann
    03/03/2022, 14:32
  4. 10. Navigating Change and Improving Outcomes: Patient-Centered Strategies for the Next Decade
    Kavita K. Mishra (University of California San Francisco)
    03/03/2022, 14:41
  5. 15. Ophthalmic advances in proton beam radiotherapy for ocular tumours
    Bertil Damato
    03/03/2022, 15:14
  6. 17. Surgical experience and RT toxicity with a dedicated ocular beamline: Orsay experience
    Nathalie Cassoux
    03/03/2022, 15:23
  7. 18. Best practices from the Chicago Proton Center gantry set-up: Opportunities and Challenges
    Rashmi Kapur
    03/03/2022, 15:32
  8. 16. Surgical best practices and potential pitfalls for proton ocular RT: An ophthalmologist perspective
    Ann Schalenbourg
    03/03/2022, 15:41
  9. 5. Delivery of optimal ocular proton beams in the next decade?
    Andrzej Kacperek (University College London)
    03/03/2022, 16:20
  10. 1. The long-term Nice experience with a dedicated proton eyeline: what can we change without compromising clinical outcomes?
    Joël Hérault (IMPT-Centre Antoine Lacassagne)
    03/03/2022, 16:30
  11. 8. Treating ocular melanoma with a modified pencil-beam-scanning system: a dosimetric study
    roelf slopsema (Emory University)
    03/03/2022, 16:40
  12. 2. Characterization of the non-dedicated scanning proton beamline for ocular treatment and clinical workflow at CNAO
    MARIO CIOCCA (Fondazione CNAO)
    03/03/2022, 16:50
  13. 4. First experience in the Netherlands: Workflow, characterization and multicenter comparison of the HollandPTC ocular beamline
    Kees Spruijt
    03/03/2022, 17:00
  14. 7. Commissioning a commercial eye treatment solution - experience at WPE
    Benjamin Koska (WPE)
    03/03/2022, 17:20
  15. 6. Implementation of Gantry-Based Treatment at the Mayo Clinic: brass-free and auto-gated
    Amanda Deisher (Mayo Clinic - Rochester)
    03/03/2022, 17:30
  16. 3. 3-D planning and multi-field treatment without using an ocular beamline
    William Hartsell (Northwestern Medicine Proton Center)
    03/03/2022, 17:40
  17. 20. High resolution MR-imaging for ocular proton therapy planning
    Jan-Willem Beenakker (Leiden University Medical Center)
    04/03/2022, 14:04
  18. 21. MRI evaluation for proton beam treatment planning
    Berit Verbist (Leiden University Medical Centre)
    04/03/2022, 14:13
  19. 22. Strengths and weaknesses of different imaging modalities, an ophthalmologists perspective with focus on treatment planning
    Antonia Joussen
    04/03/2022, 14:22
  20. 23. From clip-based to clipless treatment
    Jan Hrbacek (PSI - Paul Scherrer Institut)
    04/03/2022, 14:31
  21. 26. EYEPLAN for Proton Radiation Therapy of Ocular Melanoma: UCSF Experience
    Inder Daftari (University of California- San Francisco)
    04/03/2022, 15:04
  22. 25. From EyePlan to Octopus: From model based to 3D planning
    Jens Heufelder
    04/03/2022, 15:13
  23. 27. Experience with the RayOcular TPS – from initial requirements to treated patients at WPE
    Jörg Wulff
    04/03/2022, 15:22
  24. 28. Planning Eye Treatments in a Spot Scanning Gantry with Monte Carlo Calculated Beamlets
    Jon Kruse
    04/03/2022, 15:31
  25. 29. Treatment planning systems for ocular treatment with carbon-ion beams
    Nobuyuki Kanematsu (National Institutes for Quantum Science and Technology)
    04/03/2022, 15:40
  26. 34. Overview of patient set-up and delivery with tips
    Helen Shih (Massachusetts General Hospital)
    04/03/2022, 16:14
  27. 32. A challenging case of a large conjunctival squamous cell carcinoma
    Roi Dagan
    04/03/2022, 16:23
  28. 33. CT based simulation utilizing MRI and scleral clips
    Lia Halasz (University of Washington)
    04/03/2022, 16:32
  29. 35. Proton Re-irradiation for Choroidal Melanomas
    remi Dendale (INSTITUT CURIE ORSAY)
    04/03/2022, 16:41
  30. 31. Eye Tracking technologies for positioning and motion management in Ocular Proton Therapy
    Riccardo Via (PSI - Paul Scherrer Institut)
    04/03/2022, 16:50
  31. 36. Spatially fractionated proton therapy for eye cancer - Feasibility study
    Jan Swakon
    04/03/2022, 17:24
  32. 40. QA of ocular treatments at Massachusetts General
    Alexei Trofimov (Massachusetts General Hospital)
    04/03/2022, 17:33
  33. 38. In-house developed tools for QA of dedicated ocular beam line
    Jessica Scholey (University of California San Francisco)
    04/03/2022, 17:42
  34. 37. Aspects of the Ocular Quality Assurance Program at the Centre de Protonthérapie d’Orsay
    Catherine Nauraye
    04/03/2022, 17:51
  35. 39. Daily QA procedures at UFHPTI
    Maria Mamalui
    04/03/2022, 18:00